Unknown PHASE1 INTERVENTIONAL 1-arm NCT01962233

Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Hypoxic Ischemic Encephalopathy

Safety and Efficacy Investigation of Patients With Hypoxic Ischemic Encephalopathy by Transplantation of Umbilical Cord Derived Mesenchymal Stem Cells

Sponsor: Hebei Medical University

Conditions Hypoxic Ischemic Encephalopathy

Interventions mesenchymal stem cells

Updated 6 times since 2017 Last updated: Oct 10, 2013 Started: Sep 30, 2013 Primary completion: Dec 31, 2013 Completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01962233, this PHASE1 trial focuses on Hypoxic Ischemic Encephalopathy and remains ongoing. Sponsored by Hebei Medical University, it has been updated 6 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1
Feb 2017 — Jun 2018 [monthly]

Unknown Status PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE1

First recorded

Sep 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hebei Medical University

Data source: Hebei Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shijiazhuang, China